Showing results (611-620 of 738) with videos related to
Sort By:
Pageof 74
Journal of Blood Medicine|March 19, 2020
Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug EvaluationVincenzo Russo, Andrea Paccone, Anna Rago, et al.Journal of Blood Medicine|January 11, 2020
The Effects of Hydroxyurea Therapy on the Six-Minute Walk Distance in Patients with Adult Sickle Cell Anemia: An Echocardiographic StudyTaysir Garadah, Fatema Mandeel, Ahmed Jaradat, et al.Journal of Blood Medicine|January 16, 2019
Associations between iron deficiency anemia and clinical features among pregnant women: a prospective cohort study [Retraction]Journal of Blood Medicine|January 16, 2019
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective surveyRolando Innocenti, Luigi Rigacci, Umberto Restelli, et al.Journal of Blood Medicine|January 16, 2019
Association between serum zinc and copper levels and antioxidant defense in subjects infected with human T-lymphotropic virus type 1Samaneh Abolbashari, Susan Darroudi, Maryam Tayefi, et al.Journal of Blood Medicine|March 27, 2020
Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia PatientsEhsan Farzadfard, Tahereh Kalantari, Gholamhossein TamaddonJournal of Blood Medicine|June 12, 2025
Thrombotic Thrombocytopenic Purpura and Evans Syndrome: Validating and Exploring 20 Years of Routine Hospital CareDana Audrey Lawrie, Dennis Lund Hansen, Thomas Leineweber Kristensen, et al.Journal of Blood Medicine|October 9, 2025
Erythrocyte Alloimmunization and Transfusion Strategies in Sickle Cell Disease: A Single-Center AnalysisAbdulaziz Yusuf, Abrar Ahmad, Hesham A El-Beshbishy, et al.Journal of Blood Medicine|October 7, 2025
Non-Traumatic Fat Embolism Syndrome in Two HbSS Sickle Cell Disease Patients: A Case Series and ReviewMohammed Amouri Alzayer, Salah Abohelaika, Mousa Alhaddad, et al.Journal of Blood Medicine|June 30, 2025
Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United KingdomMark Drummond, Carlo Finelli, Fjoralba Kristo, et al.Pageof 74